Zomedica Corp.
ZOMDF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001684144
No open-market purchases or sales by Zomedica Corp. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $9.50K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −1 vs. previous quarter
- 7
- 13F valueReported value at the end of Q2 2026
- $9.50K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ZOMDF, Q2 2026
No superinvestor reported holding ZOMDF at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Zomedica Corp. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 26, 2026 (view filing)7:41 AM ET | May 21 | 5 days | Klass Russell KevinSr. Vice President, Sales | PPurchaseCommon Stock, without par value | +104.0K | $0.103 | +$10.7K | New position104.0K after | |
| May 21, 2026 (view filing)4:15 PM ET | May 18-20 | 3 daysLate | Powers Johnny DDirector | PPurchaseCommon Stock, without par value | +197.5K | $0.103 | +$20.3K | +4.7%4.42M after | 2 lots |
| May 21, 2026 (view filing)4:15 PM ET | May 19 | 2 days | Powers Johnny DDirector | PPurchaseCommon stock, without par value | +2.48K | $0.103 | +$255.96 | +0.1%4.33M after | |
| May 21, 2026 (view filing)4:15 PM ET | May 20-21 | 1 day | Klass Russell KevinOther: Sr. Vice President, Sales | PPurchaseCommon Stock, without par value | +216.9K | $0.1051 | +$22.8K | +3.7%6.00M after | 3 lots |
| May 14, 2026 (view filing)4:16 PM ET | May 12-13 | 2 days | Powers Johnny DDirector | PPurchaseCommon Stock, without par value | +300.0K | $0.1057 | +$31.7K | +7.6%4.22M after | 2 lots |
| May 11, 2026 (view filing)4:16 PM ET | May 8 | 3 days | Powers Johnny DDirector | PPurchaseCommon Stock, without par value | +108.9K | $0.112 | +$12.2K | +3.2%3.53M after | |
| May 11, 2026 (view filing)4:16 PM ET | May 11 | Same day | Powers Johnny DDirector | PPurchaseCommon stock, without par value | +391.1K | $0.113 | +$44.2K | +11.1%3.92M after | |
| May 8, 2026 (view filing)4:15 PM ET | May 8 | Same day | Heaton Larry C IICEO | PPurchaseCommon Stock, without par value | +250.0K | $0.11 | +$27.5K | +25.0%1.25M after | |
| Nov 14, 2025 (view filing)8:17 AM ET | Nov 13 | 1 day | Klass Russell KevinSr Vice President, Sales | PPurchaseCommon Stock, without par value | +150.0K | $0.097 | +$14.6K | +2.7%5.78M after | |
| Nov 12, 2025 (view filing)6:06 AM ET | Nov 10 | 2 days | Klass Russell KevinSr Vice President, Sales | PPurchaseCommon Stock, without par value. | +120.0K | $0.098 | +$11.8K | +2.2%5.63M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Zomedica Corp. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ancora Advisors, LLC | 83,610 | $8.35K | 0.00% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 4,800 | $480 | 0.00% | 00.0% | Unchanged |
| Gill Capital Partners, LLC | 2,719 | $272 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 2,200 | $220 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 1,000 | $100 | 0.00% | +1,000 | New |
| Bogart Wealth, LLC | 680 | $68 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 86 | $9 | 0.00% | +86 | New |